Pascal and Francis Bibliographic Databases

Help

Search results

Your search

ti.\*:("Isepamicin once a day : enhancing traditional aminoglycoside therapy. Meeting")

Results 1 to 20 of 20

  • Page / 1
Export

Selection :

  • and

Isepamicin once a day : enhancing traditional aminoglycoside therapy. MeetingJournal of chemotherapy. 1995, Vol 7, issn 1120-009X, 173 p., SUP2Conference Proceedings

Auditory impairment in guinea pigs treated with isepamicinFREDELIUS, L; BAMONTE, F; DIONISOTTI, S et al.Journal of chemotherapy. 1995, Vol 7, pp 71-76, issn 1120-009X, SUP2Conference Paper

An overview of the safety of isepamicin in adultsBLUM, D.Journal of chemotherapy. 1995, Vol 7, pp 87-93, issn 1120-009X, SUP2Conference Paper

Evaluation of the efficacy and safety of isepamicin in the treatment of various bacterial infectionsPETRIKKOS, G; GIAMARELLOU, H; TSAGARAKI, C et al.Journal of chemotherapy. 1995, Vol 7, pp 161-164, issn 1120-009X, SUP2Conference Paper

Isepamicin versus amikacin in the treatment of urinary tract infectionSTURM, W.Journal of chemotherapy. 1995, Vol 7, pp 149-154, issn 1120-009X, SUP2Conference Paper

Once-daily versus multiple-daily dosing of aminoglycosidesCRAIG, W. A.Journal of chemotherapy. 1995, Vol 7, pp 47-52, issn 1120-009X, SUP2Conference Paper

Pharmacokinetics of isepamicinBARR, W. H; COLUCCI, R; RADWANSKI, E et al.Journal of chemotherapy. 1995, Vol 7, pp 53-61, issn 1120-009X, SUP2Conference Paper

Pharmacokinetics of isepamicin in paediatric patientsSCAGLIONE, F; VIGANO, A; COLUCCI, R et al.Journal of chemotherapy. 1995, Vol 7, pp 63-69, issn 1120-009X, SUP2Conference Paper

The role of aminoglycosides in modern therapyBEAUCAIRE, G.Journal of chemotherapy. 1995, Vol 7, pp 111-123, issn 1120-009X, SUP2Conference Paper

A randomised comparison of isepamicin and amikacin in the treatment of bacterial infections in paediatric patientsVIGANO, A; PRINCIPI, N.Journal of chemotherapy. 1995, Vol 7, pp 95-101, issn 1120-009X, SUP2Conference Paper

Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemiaBEAUCAIRE, G.Journal of chemotherapy. 1995, Vol 7, pp 165-173, issn 1120-009X, SUP2Conference Paper

Overview of the efficacy of isepamicin in the adult core clinical trial programmeCARBON, C.Journal of chemotherapy. 1995, Vol 7, pp 79-85, issn 1120-009X, SUP2Conference Paper

The efficacy and safety of isepamicin compared with amikacin in the treatment of intra-abdominal infectionsLEAL DEL ROSAL, P.Journal of chemotherapy. 1995, Vol 7, pp 143-148, issn 1120-009X, SUP2Conference Paper

Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infectionsRODRIGUEZ-NORIEGA, E; ESPARZA-AHUMADA, S; MORFIN-OTERO, R et al.Journal of chemotherapy. 1995, Vol 7, pp 155-160, issn 1120-009X, SUP2Conference Paper

The most frequently occurring aminoglycoside resistance mechanisms : combined results of surveys in eight regions of the worldJournal of chemotherapy. 1995, Vol 7, pp 17-30, issn 1120-009X, SUP2Conference Paper

The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin : a new broad-spectrum aminoglycosideMILLER, G. H; SABATELLI, F. J; NAPLES, L et al.Journal of chemotherapy. 1995, Vol 7, pp 31-44, issn 1120-009X, SUP2Conference Paper

Comparaison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by Gram-negative organismsCOVI, M; VELLUTI, G.Journal of chemotherapy. 1995, Vol 7, pp 137-142, issn 1120-009X, SUP2Conference Paper

Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patientsHERBRECHT, R; BLAISE, D; ESPINOUSE, D et al.Journal of chemotherapy. 1995, Vol 7, pp 103-110, issn 1120-009X, SUP2Conference Paper

The efficacy and safety of isepamicin and ceftazidime compared with amikicin and ceftazidime in acute lower respiratory tract infectionCOLARDYN, F.Journal of chemotherapy. 1995, Vol 7, pp 129-135, issn 1120-009X, SUP2Conference Paper

Isepamicin (SCH 21420, 1-N-HAPA gentamicin B) : microbiological characteristics including antimicrobial potency and spectrum of activityJONES, R. N.Journal of chemotherapy. 1995, Vol 7, pp 7-16, issn 1120-009X, SUP2Conference Paper

  • Page / 1